# US 2010/0306878 A1 · Highly efficient suppressor-dependent protein expression in plants with a viral vector

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0306878 A1
- Document ID: US20100306878A1
- Status: Published application
- Kind: A1
- Application number: 12/714,057
- Filed: 2010-02-26
- Published: 2010-12-02
- Earliest claimed: 2009-02-26
- Assignees: Baylor University
- Inventors: Christopher M. Kearney; Zun Liu
- Web page: https://patentgrep.com/patent/US20100306878A1

## CPC

- C12N 15/8203: {Virus mediated transformation}
- C12N 15/8205: {Agrobacterium mediated transformation}
- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- C12N 15/8257: {for the production of primary gene products, e.g. pharmaceutical products, interferon}
- C12N 15/8258: {for the production of oral vaccines (antigens) or immunoglobulins}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A series of viral vectors derived from foxtail mosaic virus, sunn hemp mosaic virus and white clover mosaic virus sequences, and which are capable of expressing heterologous proteins in plants, including the tobacco, Nicotiana benthamiana, and cowpea, bean, and other legumes with the properties of unusually limited expression in the absence of gene silencing suppressors and high level expression in their presence. In a preferred embodiment, these viral vectors may be introduced via agroinoculation, and expression of the heterologous gene may be inducible with little or no leakiness in the absence of induction.

## Claims

### Claim 1

A viral vector system comprising:
1) a viral vector carried on a binary vector,
wherein the viral vector is expressed via a viral vector promoter, with expression terminating via a viral vector polyA signal/transcription terminator at the 3′ end of the viral vector, and the viral vector comprises a deleted foxtail mosaic virus (FoMV) full length cDNA;
wherein the deleted FoMV full length cDNA is a modified wildtype FoMV full length cDNA such that the TGB2 and TGB3 genes are deleted, all bases except the beginning of the TGB1 gene are deleted, all bases except the 3′ end of the CP gene are deleted, the subgenomic promoter of subgenomic RNA1 is retained, and the start codon of the TGB1 open reading frame has been mutated to be non-functional;
wherein the beginning of the TGB1 open reading frame is 30% or less of the initial sequence of the open reading frame of TGB1; and
wherein the 3′ end of the CP gene is 30% or less of the terminal sequence of the CP FoMV gene; and
2) a second binary vector carrying a gene for a silencing suppressor, driven by a silencing suppressor promoter.

### Claim 2 (depends on 1)

The viral vector system of claim 1, wherein a heterologous gene has been inserted into restriction sites at the 3′ end of the subgenomic promoter of subgenomic RNA1.

### Claim 3 (depends on 1)

The viral vector system of claim 1, wherein the silencing suppressor is p19 or HcPro, and the silencing suppressor promoter is 35S.

### Claim 4 (depends on 1)

The viral vector system of claim 1, wherein the viral vector promoter is an XVE/estradiol activated promoter of pER8 or a constitutive promoter, and the second binary vector comprises an XVE transcription factor gene and the silencing suppressor promoter is an XVE/estradiol activated promoter.

### Claim 5 (depends on 1)

A process for expressing genes in a plant, comprising:
agroinoculating the plant with the viral vector system of claim 1.

### Claim 6 (depends on 5)

The process of claim 5, wherein the plant is Nicotiana benthamiana, lentil, Medicagol trunculata, barley, wheat or switchgrass.

### Claim 7 (depends on 5)

The process of claim 5, wherein the plant is classified in the taxonomic family of Fabaceae or Poaceae.

### Claim 8 (depends on 4)

A process for expressing genes in a plant, comprising:
agroinoculating the plant with the viral vector system of claim 4 with the two binary vectors each in a separate Agrobacterium line.

### Claim 9 (depends on 8)

The process of claim 8, further comprising induction of the XVE/estradiol activated promoter with estradiol.

### Claim 10 (depends on 9)

The process of claim 9, wherein the induction is carried out by either root drench or syringe injection of estradiol.

### Claim 11

A viral vector system comprising:
1) a binary vector containing a viral vector,
wherein the viral vector is expressed via a viral vector promoter, with expression terminating via a viral vector polyA signal/transcription terminator at the 3′ end of the viral vector, and the viral vector comprises a deleted sunn hemp mosaic virus (SHMV) full length cDNA,
wherein the deleted SHMV full length cDNA is a modified wildtype SHMV full length cDNA such that all bases except the 5′ end of the CP gene are deleted, and wherein the start codon of the CP open reading frame has been mutated to be non-functional; and
wherein the 5′ end of the CP gene is the terminal 20% or less of the 5′ end of the CP ORF sequence; and
2) a second binary vector carrying a gene for a silencing suppressor, driven by a silencing suppressor promoter.

### Claim 12 (depends on 11)

The viral vector of claim 11, wherein a heterologous gene has been inserted into the sites where the CP gene was deleted.

### Claim 13 (depends on 11)

The viral vector system of claim 11, wherein the silencing suppressor is p19 or HcPro, and the silencing suppressor promoter is 35S.

### Claim 14 (depends on 11)

The viral vector system of claim 11, wherein the viral vector promoter is an XVE/estradiol activated promoter of pER8 or a constitutive promoter, and the second binary vector comprises an XVE transcription factor gene and the silencing suppressor promoter is an XVE/estradiol activated promoter.

### Claim 15 (depends on 11)

A process for expressing genes in a plant, comprising:
agroinoculating the plant with the binary vector of claim 11.

### Claim 16 (depends on 18)

The process of claim 18, wherein the plant is Nicotiana benthamiana, bean, Medicago trunculata, or cowpea.

### Claim 17 (depends on 14)

A process for expressing genes in a plant, comprising:
agroinoculating the plant with the viral vector system of claim 14.

### Claim 18 (depends on 17)

The process of claim 17, further comprising induction of the XVE/estradiol activated promoter with estradiol.

### Claim 19 (depends on 18)

The process of claim 18, wherein the induction is carried out by either root drench or syringe injection of estradiol.

### Claim 20

A viral vector system comprising:
1) a viral vector carried on a binary vector,
wherein, the viral vector is expressed via a viral vector promoter system, with expression terminating via a viral vector polyA signal/transcription terminator at the 3′ end, and the viral vector comprises a deleted white clover mosaic virus (WClMV) sequence full length cDNA;
wherein the deleted WClMV sequence full length cDNA is a modified wildtype WClMV full length cDNA such that the TGB2 and TGB3 genes are deleted, all bases except the initial portion of the TGB1 gene are deleted, all bases except the 3′ end of the CP gene are deleted, the subgenomic promoter of subgenomic TGB1 RNA is retained, and the start codon of the TGB1 open reading frame has been mutated to be non-functional;
wherein the beginning of the TGB1 open reading frame is the initial 30% or less of the open reading frame of TGB1; and
wherein the 3′ end of the CP gene is the terminal 30% or less of the 3′ terminal sequence of the CP WClMV gene; and
2) a second binary vector carrying a gene for a silencing suppressor, driven by a silencing suppressor promoter.

### Claim 21 (depends on 20)

The viral vector of claim 20, wherein a heterologous gene has been inserted into restriction sites at the 3′ end of the subgenomic promoter of subgenomic TGB1 RNA.

### Claim 22 (depends on 20)

The viral vector system of claim 20, wherein the silencing suppressor is p19 or HcPro, and the silencing suppressor promoter is 35S.

### Claim 23 (depends on 20)

The viral vector system of claim 20, wherein the viral vector promoter is an XVE/estradiol activated promoter of pER8 or a constitutive promoter, and the second binary vector comprises an XVE transcription factor gene and the silencing suppressor promoter is an XVE/estradiol activated promoter.

### Claim 23 (depends on 20)

A process for expressing genes in a plant, comprising:
agroinoculating the plant with the viral vector of claim 20.

### Claim 24 (depends on 23)

The process of claim 23, wherein the plant is Nicotiana benthamiana, chickpea, lentil, or pea.

### Claim 25 (depends on 23)

A process for expressing genes in a plant, comprising:
agroinoculating the plant with the viral vector system of claim 23.

### Claim 26 (depends on 25)

The process of claim 25, further comprising induction of the XVE/estradiol activated promoter with estradiol.

### Claim 27 (depends on 26)

The process of claim 26, wherein the induction is carried out by either root drench or syringe injection of estradiol.

### Claim 28

A method of expressing a gene in a plant comprising the steps of:
(a) delivering a viral vector to the plant;
wherein the viral vector is carried by a viral binary vector and the viral vector is expressed via a viral vector promoter, with expression terminating via a viral vector polyA signal/transcription terminator at the 3′ end of the viral vector, and the viral vector comprises a deleted foxtail mosaic virus (FoMV) full length cDNA;
wherein the deleted FoMV full length cDNA is a modified wildtype FoMV full length cDNA such that the TGB2 and TGB3 genes are deleted, all bases except the beginning of the TGB1 gene are deleted, all bases except the 3′ end of the CP gene are deleted, the subgenomic promoter of subgenomic RNA1 is retained, and the start codon of the TGB1 open reading frame has been mutated to be non-functional;
wherein the beginning of the TGB1 open reading frame is 30% or less of the initial sequence of the open reading frame of TGB1; and
wherein the 3′ end of the CP gene is 30% or less of the terminal sequence of the CP FoMV gene
(b) a silencing suppressor
wherein the silencing suppressor is delivered via a silencing suppressor vector comprising a silencing suppressor open reading frame, and wherein the expression of the silencing suppressor open reading frame is driven by a silencing suppressor promoter and terminated by a silencing suppressor polyA signal transcription terminator;
wherein the viral vector may be constitutively or inducibly expressed; and
wherein the silencing suppressor vector may be constitutively or inducibly expressed.

### Claim 29

A method of expressing a gene in a plant comprising the steps of:
(a) delivering a viral vector to the plant;
wherein the viral vector is carried by a viral binary vector and the viral vector is expressed via a viral vector promoter, with expression terminating via a viral vector polyA signal/transcription terminator at the 3′ end of the viral vector, and the viral vector comprises a deleted sunn hemp mosaic virus (SHMV) full length cDNA,
wherein the deleted SHMV full length cDNA is a modified wildtype SHMV full length cDNA such that all bases except the 5′ end of the CP gene are deleted, and wherein the start codon of the CP open reading frame has been mutated to be non-functional;
wherein the 5′ end of the CP gene is the terminal 20% or less of the 5′ end of the CP ORF sequence; and
(b) a silencing suppressor
wherein the silencing suppressor is delivered via a silencing suppressor vector comprising a silencing suppressor open reading frame, and wherein the expression of the silencing suppressor open reading frame is driven by a silencing suppressor promoter and terminated by a silencing suppressor polyA signal/transcription terminator;
wherein the viral vector may be constitutively or inducibly expressed; and
wherein the silencing suppressor vector may be constitutively or inducibly expressed.

### Claim 30

A method of expressing a gene in a plant comprising the steps of:
(a) delivering a viral vector to the plant;
wherein the viral vector is carried by a viral binary vector and the viral vector is expressed via a viral vector promoter system, with expression terminating via a viral vector polyA signal/transcription terminator at the 3′ end, and the viral vector comprises a deleted WClMV sequence full length cDNA;
wherein the deleted WClMV sequence full length cDNA is a modified wildtype WClMV full length cDNA such that the TGB2 and TGB3 genes are deleted, all bases except the initial portion of the TGB1 gene are deleted, all bases except the 3′ end of the CP gene are deleted, the subgenomic promoter of subgenomic RNA1 is retained, and the start codon of the TGB1 open reading frame has been mutated to be non-functional;
wherein the beginning of the TGB1 open reading frame is the initial 30% or less of the open reading frame of TGB1; and
wherein the 3′ end of the CP gene is the terminal 30% or less of the 3′ terminal sequence of the CP WClMV gene; and
(b) a silencing suppressor
wherein the silencing suppressor is delivered via a silencing suppressor vector containing a silencing suppressor open reading frame, and wherein the expression of the silencing suppressor open reading frame is driven by an inducible silencing suppressor promoter system and terminated by a silencing suppressor polyA signal/transcription terminator;
wherein the viral vector may be constitutively or inducibly expressed; and
wherein the silencing suppressor vector may be constitutively or inducibly expressed.
